These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20004244)
1. Recent advances in the manipulation of murine gene expression and its utility for the study of human neurological disease. Cazzin C; Ring CJ Biochim Biophys Acta; 2010 Oct; 1802(10):796-807. PubMed ID: 20004244 [TBL] [Abstract][Full Text] [Related]
2. Genetically modified mice in neuropharmacology. Brusa R Pharmacol Res; 1999 Jun; 39(6):405-19. PubMed ID: 10373238 [TBL] [Abstract][Full Text] [Related]
3. Mouse models of neurological disorders--a comparison of heritable and acquired traits. Harper A Biochim Biophys Acta; 2010 Oct; 1802(10):785-95. PubMed ID: 20510357 [TBL] [Abstract][Full Text] [Related]
4. Transgenic mouse models of dopamine deficiency. Chen L; Zhuang X Ann Neurol; 2003; 54 Suppl 6():S91-102. PubMed ID: 12891659 [TBL] [Abstract][Full Text] [Related]
8. Generation of a neurodegenerative disease mouse model using lentiviral vectors carrying an enhanced synapsin I promoter. Matsuzaki Y; Oue M; Hirai H J Neurosci Methods; 2014 Feb; 223():133-43. PubMed ID: 24361760 [TBL] [Abstract][Full Text] [Related]
9. Lentiviruses allow widespread and conditional manipulation of gene expression in the developing mouse brain. Artegiani B; Calegari F Development; 2013 Jul; 140(13):2818-22. PubMed ID: 23757413 [TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases. Jerusalinsky D; Baez MV; Epstein AL J Physiol Paris; 2012 Jan; 106(1-2):2-11. PubMed ID: 22108428 [TBL] [Abstract][Full Text] [Related]
11. MRI of mouse models of neurological disorders. Anderson SA; Frank JA NMR Biomed; 2007 May; 20(3):200-15. PubMed ID: 17451184 [TBL] [Abstract][Full Text] [Related]
12. Prospects of treating neurological diseases by gene therapy. Lundstrom K Curr Opin Investig Drugs; 2007 Jan; 8(1):34-40. PubMed ID: 17263183 [TBL] [Abstract][Full Text] [Related]
13. Mouse models for neurological disease. Hafezparast M; Ahmad-Annuar A; Wood NW; Tabrizi SJ; Fisher EM Lancet Neurol; 2002 Aug; 1(4):215-24. PubMed ID: 12849454 [TBL] [Abstract][Full Text] [Related]
15. [Genetically engineered mice: mouse models for cancer research]. SzymaĆska H Postepy Hig Med Dosw (Online); 2007 Oct; 61():639-45. PubMed ID: 17971765 [TBL] [Abstract][Full Text] [Related]
16. Transgenic animals as models of neurodegenerative diseases in humans. Theuring F; Thunecke M; Kosciessa U; Turner JD Trends Biotechnol; 1997 Aug; 15(8):320-5. PubMed ID: 9263480 [TBL] [Abstract][Full Text] [Related]
17. Gene-targeting technologies for the study of neurological disorders. Beglopoulos V; Shen J Neuromolecular Med; 2004; 6(1):13-30. PubMed ID: 15781974 [TBL] [Abstract][Full Text] [Related]
18. Analysis of human neurological disorders using mutagenesis in the mouse. Oliver PL; Davies KE Clin Sci (Lond); 2005 May; 108(5):385-97. PubMed ID: 15831088 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in the pharmacology of neurological gene therapy. Lowenstein PR; Castro MG Curr Opin Pharmacol; 2004 Feb; 4(1):91-7. PubMed ID: 15018845 [TBL] [Abstract][Full Text] [Related]
20. Transgene-like animal models using intronic microRNAs. Lin SL; Chang SJ; Ying SY Methods Mol Biol; 2013; 936():279-94. PubMed ID: 23007516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]